AVNS Stock Analysis: Buy, Sell, or Hold?
AVNS - Avanos Medical, Inc.
$24.71
0.00 (0.00%)
▲
5d:
-0.36%
30d:
+0.2%
90d:
+65.84%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 05, 2026
0d
Get Alerted When AVNS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AVNS trades at premium valuation expecting 12.4% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: AVNS trades at premium valuation expecting 12.4% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.84
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.01
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AVNS is currently trading at $24.71, which is considered slightly high relative to its 30-day fair value range of $17.89 to $26.74. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.8) compared to its historical average (13.9). At these levels, the market is pricing in 12.4% annual earnings growth.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $14.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AVNS is in a strong uptrend. The price is currently testing key support at $24.64. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $14.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$17.89 -
$26.74
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
59.0%
All Signals
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 43.3% above Wall St target ($14.00)
- BULLISH: Expecting earnings turnaround to 12.4% growth with 8.8% revenue growth
Trading Range Analysis
30-Day Trading Range
$17.89 -
$26.74
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$24.64
Resistance Level
$24.91
Current Trend
Strong Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.77
Wall Street Target
$14.00
(-43.3%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
-21.7%
Profit Margin
-10.4%
Valuation Premium vs History
+12.4% premium
PE vs Historical
19.8 vs 13.9
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+12.4%
(market-implied from PE analysis)
1-Year Target
$27.77
(+12%)
2-Year Target
$31.22
(+26%)
3-Year Target
$35.09
(+42%)
3-Yr Target (if PE normalizes)
(PE: 20→14)
PE COMPRESSION
$24.67
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 25.0%)
$53.88
(+118%)
Base:
(SPY PE: 19.8, Growth: 25.0%)
$48.26
(+95%)
Bear:
(PE: 13.9, Growth: 25.0%)
$33.94
(+37%)
Share & Embed Analysis
Last updated: May 16, 2026 5:31 AM ET
Data refreshes hourly during market hours. Next update: 6:31 AM
Data refreshes hourly during market hours. Next update: 6:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AVNS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Kerr Holbrook
SELL
15000 shares
2025-11-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$392 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 55 HOLD |
